The Study of Outcomes for Capd versus Hemodialysis Patients
Author(s) -
Port Friedrich K.,
Wolfe Robert A.,
Bloembergen Wendy E.,
Held Philip J.,
Young Eric W.
Publication year - 1996
Publication title -
peritoneal dialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.79
H-Index - 83
eISSN - 1718-4304
pISSN - 0896-8608
DOI - 10.1177/089686089601600614
Subject(s) - medicine , hemodialysis , peritoneal dialysis , observational study , dialysis , continuous ambulatory peritoneal dialysis , intensive care medicine , randomized controlled trial , dialysis adequacy , treatment modality , sample size determination , ambulatory , clinical trial , statistics , mathematics
Objective To discuss potential reasons for reported differences in the results of several recent studies comparing mortality risk among continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis patients, and to assess the role of statistical methods and study design.Data Sources Recent published reports comparing mortality risk among patients treated with CAPD and hemodialysis.Conclusions Differences in study design, study populations, sample size, data collection, and availability of data likely account in part for the differences in available study results. The Cox model is a valuable tool, particularly for observational studies. Observed outcome differences for CAPD and hemodialysis patients may be due to either the dialytic modality itself or other factors such as differences in patient selection, practice patterns, dialysis dose, patient compliance, etc. Relative mortality rates for hemodialysis and CAPD patients may vary by country, as these factors may differ internationally. A randomized clinical trial is necessary to best determine the effect of the modality itself.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom